107 results on '"KHAN, N."'
Search Results
2. CO30 Real-World Treatment Patterns in Patients With Biochemical Recurrence After Local Therapy for Prostate Cancer: Retrospective Analysis of a Large US Database
3. PRO74 QUALITY OF LIFE AMONG INDIVIDUALS WITH ANGELMAN SYNDROME
4. PRESCRIPTION DRUG INSURANCE AND ITS EFFECT ON UTILIZATION AND HEALTH OF THE ELDERLY: HP4
5. Selective Internal Radiotherapy (SIRT) in Metastatic Colorectal Cancer Patients with Liver Metastases: Preliminary Primary Care Resource Use and Utility Results from The Foxfire Randomised Controlled Trial
6. Recruiting Metastatic Patients into Non-Small Cell Lung Cancer Studies (NSCLC): Lessons Learned from A Non-Interventional Study of NSCLC Patients with Central Nervous System (CNS) Metastases (METS) and Non-CNS Mets
7. Non-Interventional Real-World European Study Quantifying The Burden Of Central Nervous System (CNS) Metastases On Healthcare Resource Use (HRU) In Patients With Metastatic Non-Small-Cell Lung Cancer (MNSCLC) – Results From An Interim Analysis
8. Development Of An Innovative Observational Study To Assess Multiple Sclerosis Disease Progression In Real World Clinical Practice
9. PATIENT CHARACTERISTICS AND TREATMENT AMONG ELDERLY INFLAMMATORY BOWEL DISEASE PATIENTS: A RESTROSPECTIVE DATABASE ANALYSIS
10. Estimation of Direct Medical Costs Associated with Treatment of Metastatic Melanoma in Switzerland
11. PRM159 - Non-Interventional Real-World European Study Quantifying The Burden Of Central Nervous System (CNS) Metastases On Healthcare Resource Use (HRU) In Patients With Metastatic Non-Small-Cell Lung Cancer (MNSCLC) – Results From An Interim Analysis
12. PRS75 - Recruiting Metastatic Patients into Non-Small Cell Lung Cancer Studies (NSCLC): Lessons Learned from A Non-Interventional Study of NSCLC Patients with Central Nervous System (CNS) Metastases (METS) and Non-CNS Mets
13. PCN186 - Selective Internal Radiotherapy (SIRT) in Metastatic Colorectal Cancer Patients with Liver Metastases: Preliminary Primary Care Resource Use and Utility Results from The Foxfire Randomised Controlled Trial
14. THE DEVELOPMENT AND PRELIMINARY VALIDATION OF THE MANCHESTER SLEEP SYMPTOMS INDEX (MSSI) FOR PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
15. The Development and Preliminary Validation of the Manchester Early Morning Symptoms Index (Memsi) for People With Chronic Obstructive Pulmonary Disease (Copd)
16. Mcda Approach To Ranking Rare Diseases In Russia: Preliminary Results
17. Building a real-world non-small cell lung cancer cohort by linking a claims database to oncology electronic medical records
18. PGI34 - PATIENT CHARACTERISTICS AND TREATMENT AMONG ELDERLY INFLAMMATORY BOWEL DISEASE PATIENTS: A RESTROSPECTIVE DATABASE ANALYSIS
19. PRM190 - Development Of An Innovative Observational Study To Assess Multiple Sclerosis Disease Progression In Real World Clinical Practice
20. Comparative effectiveness of angiotensin receptor blockers in chronic heart failure: A network meta-analysis
21. The efficacy and tolerability of perampanel compared to other adjunctive recently approved anti-epileptic drugs (AEDS) for the treatment of refractory partial onset seizures: A systematic review and bayesian network meta-analysis (NMA)
22. CL2 Statistical Considerations in Estimating Survival for Economic Evaluations in Oncology
23. PRM62 Time-Dependency for Treatment Sequences: A Case-Example in Epilepsy
24. PRM10 Use of VA Databases for Retrospective Studies in Ulcerative Colitis Outcomes Research
25. PMH73 Estimating Off-Label Use of Prescription Drugs: The Case of Gabapentin
26. PDB12 Comparative Effectiveness Study of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Type 2 Diabetes
27. PND24 A Review of Cost-Effectiveness Studies for Anti-Epileptic Drugs
28. PRM14 Time-Dependency for Treatment Sequences in Markov Cohort Models: A Nested Markov Modeling Approach
29. NI3 Economic Evaluation in Niche Markets: The Role of the UK's Advisory Group for National Specialised Services for Rare Diseases and Disorders
30. PHP71 IMPACT OF THE MEDICARE PART D COVERAGE GAP ON PRESCRIPTION DRUG UTILIZATION AND MEDICATION ADHERENCE
31. PCN123 - Estimation of Direct Medical Costs Associated with Treatment of Metastatic Melanoma in Switzerland
32. PMC36 VALIDITY OF SELF-REPORT WITH RESPECT TO PRESCRIPTION MEDICATIONS AMONG PREGNANT WOMEN
33. PIH7 PREDICTORS OF NON-MEDICAL USE OF PRESCRIPTION DRUGS AMONG PREGNANT WOMEN IN THE UNITED STATES
34. PHP13 MEDICARE PART D AND ITS IMPACT ON PRESCRIPTION DRUG USE
35. PMS17 NATIONAL COST OF ILLNESS STUDY COMPARING VETERAN PATIENTS WITH GOUT TO THOSE WITH DIFFICULT TO MANAGE GOUT
36. PMS11 RELATIONSHIP BETWEEN LEVELS OF PHYSICAL ACTIVITY AT WORK AND PREVALENCE OF ARTHRITIS AMONG WORKING POPULATION
37. PMS49 DRUG COVERAGE, UTILIZATION AND HEALTH AMONG ELDERLY PATIENTS WITH ARTHRITIS
38. PRS1 SMOKING CESSATION AND ITS PREDICTORS: RESULTS FROM COMMUNITY BASED PHARMACY TOBACCO CESSATION PROGRAM IN NEW MEXICO
39. PCN101 RELATIONSHIP BETWEEN HEALTH CARE SUPPLY AND MAMMOGRAPHY SCREENING?
40. PCV109 PRESCRIPTION DRUG INSURANCE AND EX ANTE MORAL HAZARD
41. PHC5 COST-EFFECTIVENESS ANALYSIS OF THROMBOPROPHYLACTIC STRATEGIES OVER ONEYEAR AFTERTOTAL KNEE REPLACEMENT IN VETERAN PATIENTS
42. PHP19 EFFECT OF PRESCRIPTION DRUG COVERAGE ON HEALTH AMONG CHRONICALLY ILL ELDERLY POPULATION
43. PHC4 COST-EFFECTIVENESS ANALYSIS OF THROMBOPROPHYLACTIC STRATEGIES OVER I YEARAFTER TOTAL HIP REPLACEMENT IN VETERAN PATIENTS
44. PDB29 RELATIONSHIP BETWEEN EATING HEALTHY FOODS AND REGULAR EXERCISE AND PHYSICAL HEALTH, MENTAL HEALTH, AND HEALTH STATUS IN TYPE II DIABETICS
45. HP4 PRESCRIPTION DRUG INSURANCE AND ITS EFFECT ON UTILIZATION AND HEALTH OF THE ELDERLY
46. PHP3I: SAFETY NET ACTIVITIES STRUCTURAL CHARACTERISTICS & MEMBERSHIP IN LOCAL HOSPITAL SYSTEMS
47. SC3 FACTORS IMPACTING MAMMOGRAPHY SCREENING IN RURAL AND URBAN AREAS
48. PRM163 - The Development and Preliminary Validation of the Manchester Early Morning Symptoms Index (Memsi) for People With Chronic Obstructive Pulmonary Disease (Copd)
49. PRM142 - THE DEVELOPMENT AND PRELIMINARY VALIDATION OF THE MANCHESTER SLEEP SYMPTOMS INDEX (MSSI) FOR PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
50. PSY99 - Mcda Approach To Ranking Rare Diseases In Russia: Preliminary Results
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.